Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Ginkgo Bioworks Holdings Inc.’s current trading price is -45.17% away from its 52-week high, while its distance from the 52-week low is 72.32%. The stock’s price range during this period has varied between $1.12 and $3.52. The company, active in the Healthcare sector, saw a trading volume of around 29.77 million for the day, considerably higher average daily volume of 22.26 million observed over the last three months.
Ginkgo Bioworks Holdings Inc. (DNA) currently has a stock price of $1.93. The stock saw a sharp increase in the last trading session, hitting a high of $1.9798 after opening at $1.92. The lowest recorded price for the day was $1.90 before it closed at $1.96.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Ginkgo Bioworks Holdings Inc.’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $3.52 on 10/04/22, and the lowest price during the same period was recorded at $1.12 on 05/03/23.
How Financial Performance Impacts Market Capitalization
Ginkgo Bioworks Holdings Inc. (DNA) has experienced a quarterly decline of -1.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.88B and boasts a workforce of 1292 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8055, with a change in price of +0.6600. Similarly, Ginkgo Bioworks Holdings Inc. recorded 22,701,012 in trading volume during the last 100 days, posting a change of +51.97%.
How DNA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
DNA Stock Stochastic Average
As of today, the raw stochastic average of Ginkgo Bioworks Holdings Inc. over the past 50 days is 38.19%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 41.53%. Additionally, the Stochastic %K and %D values for the company were 45.90% and 50.88%, respectively, over the past 20 days.
DNA Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 14.20%.However, over the last six months, we can see a weaker performance of 46.21%. Over the last 30 days, the price of DNA has fallen by 18.40%. And in the last five days, it has fallen by -7.21%.
